U.S. Medical Devices (In Vitro Diagnostics, Medical Devices, Medical Equipment, and Medical Supplies) is an industry undergoing redefinition and revitalization. Five technologies and a myriad of innovations are converging to enable the creation and development of new and/or improved products. Legislation is fostering innovations and is speeding industry change. Changes in one healthcare industry sector affect the other interrelated healthcare stakeholders. The 2012 to 2020 period will be typified by industry discontinuities, innovation and change. What worked in the past will not work in the future.

Medical device industry norms in 2020 will be radically different than they were at the end of 2011. The "Trends Shaping U.S. Medical Devices Industry Strategies" report provides insights into how the transformation of the respective United States healthcare industry stakeholders will redefine how medical devices are developed, reimbursed, launched, marketed, and who, how and where they are utilized. The report is organized to assist managers in the preparation of their annual long-term strategic and marketing plans. The "Trends Shaping U.S. Medical Devices Industry Strategies" is designed to: 1) prompt senior management to question internal assumptions and corporate strategies in order to fight "Group Think" and refine or develop strategies to better position their company to capitalize on industry change, 2) challenge the thinking of product development and marketing teams/staffs, and 3) orient individuals new to the industry.

Strategically managed companies anticipate and capitalize on industry change, innovate and prosper; the majority of companies are destined to be broken up, acquired, merged or driven out of business.